TY - JOUR
TI - Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
AU - Buske, C.
AU - Dreyling, M.
AU - Alvarez-Larrán, A.
AU - Apperley, J.
AU - Arcaini, L.
AU - Besson, C.
AU - Bullinger, L.
AU - Corradini, P.
AU - Giovanni Della Porta, M.
AU - Dimopoulos, M.
AU - D'Sa, S.
AU - Eich, H.T.
AU - Foà, R.
AU - Ghia, P.
AU - da Silva, M.G.
AU - Gribben, J.
AU - Hajek, R.
AU - Harrison, C.
AU - Heuser, M.
AU - Kiesewetter, B.
AU - Kiladjian, J.J.
AU - Kröger, N.
AU - Moreau, P.
AU - Passweg, J.R.
AU - Peyvandi, F.
AU - Rea, D.
AU - Ribera, J.-M.
AU - Robak, T.
AU - San-Miguel, J.F.
AU - Santini, V.
AU - Sanz, G.
AU - Sonneveld, P.
AU - von Lilienfeld-Toal, M.
AU - Wendtner, C.
AU - Pentheroudakis, G.
AU - Passamonti, F.
JO - ESMO open
PY - 2022
VL - 7
TODO - 2
SP - null
PB - Elsevier B.V.
SN - null
TODO - 10.1016/j.esmoop.2022.100403
TODO - null
TODO - Background: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. Methods: This consensus manuscript aims at discussing clinical evidence and providing expert advice on statements related to the management of HMs in the COVID-19 pandemic. For this purpose, an international consortium was established including a steering committee, which prepared six working packages addressing significant clinical questions from the COVID-19 diagnosis, treatment, and mitigation strategies to specific HMs management in the pandemic. During a virtual consensus meeting, including global experts and lead by the European Society for Medical Oncology and the European Hematology Association, statements were discussed and voted upon. When a consensus could not be reached, the panel revised statements to develop consensual clinical guidance. Results and conclusion: The expert panel agreed on 33 statements, reflecting a consensus, which will guide clinical decision making for patients with hematological neoplasms during the COVID-19 pandemic. © 2022 The Authors
ER -